Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2020 May 1;84(1):114–121. doi: 10.1097/QAI.0000000000002314

Table 3.

Correlations between hs-CRP and cognitive domains in PHIV with and without a neurocognitive disorder (NCD)

All
subjects
(n=211)
Controls
(n=43)
PHIV
(n=168)
PHIVs
without
NCD
(n=87)
PHIVs with
NCD
(n=81)
hs-CRP x General intelligence −.08(.22) −.02(.89) −.08(.33) .14(.19) −.33(<.01)
hs-CRP x Attention −.03(.70) −.19(.21) −.03(.70) −.01(.98) .09(.46)
hs-CRP x Motor coordination −.03(.71) .20(.20) −.08(.33) −.02(.82) −.12(.29)
hs-CRP x Visual memory −.05(.45) −.07(.68) −.03(.74) .04(.69) −.08(.50)
hs-CRP x Verbal memory −.09(.21) .07(.65) −.10(.22) −.01(.95) −.16(.16)
hs-CRP x Language −.11(.10) −.07(.65) −.11(.16) −.12(.27) −.09(.43)
hs-CRP x Visual spatial ability −.12(.08) −.06(.67) −.12(.11) .02(.85) −.24(.03)
hs-CRP x Processing speed −.11(.11) −.15(.35) −.07(.35) .08(.44) −.18(.10)
hs-CRP x Working memory −.05(.44) −.19(.22) −.01(.92) .07(.50) −.02(.85)
hs-CRP x Executive function −.11(.12) −.06(.71) −.10(.22) .04(.74) −.22(.04)

Pearson’s r correlation values are provided with p values in the brackets.